Redox homeostasis intervention strategy (RHIS) |
Glutathione (GSH) depletion and ROS generation |
Triphenylphosphonium (TPP) |
Mitochondrial oxidative stress amplifier |
[59] |
Chemodynamic therapy (CDT), photodynamic therapy (PDT) |
Ir (III) complexes |
Magnetothermogenic nanozyme |
[78] |
CDT, GSH depletion, and chemotherapy (CT) |
TPP‐PEG2K‐LND |
pH‐responsive nanoprodrug |
[79] |
Energy metabolism regulation strategy (EMRS) |
Photothermal therapy (PTT), PDT, glucose oxidase (GOx)‐induced starvation |
IR780 dye |
Deep tumor penetration |
[85] |
Sonodynamic therapy (SDT), GOx‐induced starvation |
IR780 dye |
Deep tumor penetration |
[86] |
Combination therapy |
CT, PTT |
IR780 dye |
Mitochondria‐responsive drug release |
[87] |
Radiation therapy (RT) |
TPP |
Nanoradiosensitizer to enhance RT effect |
[88] |
RT, radiodynamic therapy (RDT) |
Cationic Ru‐based photosensitizers (DBB‐Ru) |
Cationic nMOFs for mitochondria targeting |
[89] |
PTT, PDT |
IR780 |
PFOB‐based nanoliposomes act as the “Nano‐RBCs” |
[90] |
SDT, gas therapy |
IR780 |
Reverse immunosuppression |
[91] |
PTT, PDT |
DPP2+ |
New strategy to design mitochondria‐targeting photosensitizers |
[92 ] |
PDT |
TPP |
Near‐infrared (NIR) light‐activated PDT nanoplatform |
[93] |
Photochemotherapy |
Cationic Ru2+ complex |
Near infrared‐assisted Fenton reaction |
[94] |
PDT, GOx‐induced starvation |
TPP |
Self‐supply of O2 and H2O2 to enhance PDT effect |
[95] |